Nanosphere's Revenues More than Double as Loss Drops 9 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market on Thursday that its third-quarter revenues more than doubled due to grant and contract revenues and its net loss dropped 9 percent.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $729,000 for the three-month period ended Sept. 30, compared to $283,000 for the prior year third quarter. Its contract and grant revenues were roughly $422,000 for the quarter compared to $73,000 the year before, while its product sales grew to $307,000 from $210,000 year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.